Continuing on with John Boik:
SEVEN STRATEGIES FOR CANCER INHIBITION
To be clear, not all cancers develop exactly as in the scenario above. The scenario is common, however, and within it lies the foundation for all our discussion on cancer inhibition. From it we can identify seven clusters of precancerous events:
1. Induction of genetic instability. Each cancer cell carries within itself genetic instability, and this instability increases the chances the cell will be able to mutate as needed to adapt to its environment.
2. Abnormal expression of genes. In essence, the function of genes is to make proteins - a process called gene expression. When they are expressed, some genes produce proteins that inhibit cancer progression, and others produce proteins that fascilitate it. In cancer cells, abnormal expression of genes occurs, resulting in too few proteins that inhibit cancer, and too many that fascilitate it.
3. Abnormal signal transduction. Signal transduction is the movement of a signal from outside the cell towards the cell's nucleus, where it can stimulate proliferation or other activities. One important source of external signals comes from growth factors. Growth factors are solvable molecules at bind to specific receptors on the cell's surface and stimulate the cell's activities. A second source of external signals comes from cell adhesion molecules (CAMs). Cell's interact with their environment through CAMs located on their surface. Cell adhesion molecules are proteins that act like fingers to regulate the degree of contact with other cell's and tissues and inform cell's of their surroundings. Other factors are also involved in signal generation and signal transduction. For example, cancer cells can produce their own growth factors, thereby allowing self-stimulation; they can produce extra receptors for growth factors; they can produce free radicals, which can make growth factor receptors more responsive to stimulation.
4. Abnormal cell-to-cell communication. By decreasing their contact with normal cells, cancer cells are freed to act independently. As mentioned previously, cell-to-cell communication occurs via portals between adjacent cells (gap junctions)and through cell adhesion molecules. Normal cell-to-cell communication through gap junctions maintains homeostasis and discourages cancerlike behavior. Normal CAM activity keeps cells in place and prevents signal transduction that may be initiated by abnormal CAM activity.
5. Induction of angiogenesis. Angiogenesis is the growth of new blood vessels toward and within tumors (or other tissues). Solid tumors require angiogenesis in order to grow. Tumors need blood vessels to supply oxygen and nutrients, and the blood vessels created by angiogenesis provide the channel by which tumor cells metastasize to distant locations.
6. Invasion and metastasis.. Tumors can spread both locally, via invasion of adjacent tissues, and distantly, via metastasis through the blood and lymph circulation. The spread of cancer, along with uncontrolled proliferation, is a central hallmark of malignancy.
7. Immune evasion Cancer cells shield themselves from immune attack, thereby evading destruction: they can hide from immune cells by employing various camouflaging techniques or can produce immunosuppressive compounds that impair the ability of immune cells to function.
These seven event clusters provide the targets for the anticancer strategies laid out in this book. Each of the seven clusters of procancer events is illustrated in Figure 1:1.
Since each of these seven clusters is a target for therapy, we can identify seven strategies for cancer inhibition. Keep in mind that natural compounds can be used to carry out each of these seven strategies and that the best results will be seen when all seven ar used together. The seven strategies are as follows:
1. Reduce genetic instability. Genetic instability is aggravated by oxidative stress (stress caused by free radicals). Cancer cells exist in an oxidative environment k and although such an environment kills, many continue to survive. As oxidative stress increases, the declining population of surviving cells exhibits greater instability and higher mutation rates, in theory eventually producing more aggressive and successful cancers. Thus one way of reducing genetic instability is by reducing oxidative stress. Other possible means of reducing genetic instability are discussed in Chapter 2.
2. Inhibit abnormal expression of genes. One way that gene expression can be normalized is through modifying the activity of transcription factors. Transcription factors are proteins that act as switches in the nucleus to turn on gene expression. Genes that inhibit cancer progression are commonly underexpressed in cancer cells, and genes that fascilitate cancer are often overexpressed. Therefore, cancer can be inhibited by normalizing the activity of those transcription factors that control the expression of these genes. The use of natural compounds to effect transcription factors is discussed in Chapter 5.
3. Inhibit abnormal signal transduction. The movement of a signal from outside the cell toward the nucleus relies on several proteins (including kinase enzymes and ras proteins, discussed later), and so signal transduction can be inhibited by blocking the the actions of these proteins; using natural compounds for this purpose is discussed in Chapter 4. Signal transduction is a normal process needed by healthy cells, but in cancer cells the volume of signal transduction is excessive, and the signals that flow favor proliferation and spread. Thus, the intent is not to eliminate signal transduction but to bring it down to normal levels.
4. Encourage normal cell-to-cell communication. Normal cell-to-cell communication can be fostered by by improving gap junction communication and by normalizing CAM activity. Natural compounds that encourage normal cell-to-cell communication are discussed in Chapter 6.
5. Inhibit tumor angiogenesis. Like signal transduction, angiogenesis is a normal process; it is needed during wound healing and in other situations. Angiogenesis in tumors, however, unlike that in normal conditions, is uncontrolled and ongoing. Our intent then is not to eliminate angiogenesis but to normalize its occurance by normalizing the factors that control it. Angiogenesis is most successful if certain chemicals called angiogenesis factors are present, as well as certain environmental conditions , such as hypoxia (low-oxygen) ones. Cancer can be inhibited by blocking the release or action of angiogenic factors or by otherwise altering the local environment to inhibit tumor angiogenesis. Natural compounds that that inhibit tumor angiogenesis are discussed in Chapters 7 and 8.
6. Inhibit invasion and metastasis. Invasion requires enzymatic digestion of the healthy tissue surrounding the tumor. It also requires the migration of tumor cells. Invasion can be reduces by inhibiting enzymes that digest local tissues, by protecting normal tissues from the enzymes, and by reducing the ability of tumor cells to migrate. Natural compounds that inhibit invasion are discussed in Chapter 9. Metastasis requires that cells detach from the primary tumor, enzymatically digest blood vessel walls to gain access to and exit from the blood circulation, and evade the immune system while in circulation. This metastasis can be checked by inhibiting any one of these processes. Natural compounds that do so are discussed in Chapter 10.
7. Increase the immune response. The immune response against cancer cells can be increased by stimulating the immune system and by reducing the ability of cancer cells to evade immune attack. Both actions are best taken in tandem, since without prevention of immune evasion, immune stimulation will have little benefit; healthy, vital immune cells can destroy cancer cells, but only if the cancer cells can be recognized as foreign to the body. Chapters 11 and 12 discuss the use of natural compounds to stimulate the immune system and inhibit immune evasion.
When natural compounds are used in these strategies, some will directly inhibit cancer cells , causing them to die, revert to normalcy (a process called differentiation), or just stop proliferating. Others will inhibit cancer progression indirectly by inducing changes in the local environment that are unfavorable to angiogenesis, invasion, or metastasis. This might include, for example, inhibiting the enzymes produced by cancer cells that allow invasion. Thus we can group natural compounds into two broad categories of action: those that act directly on cancer cells to inhibit proliferation (called direct-action compounds) and those that inhibit cancer progression by affecting tissues or compounds outside the cancer cell (called indirect-acting compounds). In addition we can add a third category: compounds that inhibit cancer through stimulating the immune system. Although immune attack produces a direct cytotoxic effect against cancer cells, immune stimulants themselves generally do not.
SEVEN STRATEGIES FOR CANCER INHIBITION
To be clear, not all cancers develop exactly as in the scenario above. The scenario is common, however, and within it lies the foundation for all our discussion on cancer inhibition. From it we can identify seven clusters of precancerous events:
1. Induction of genetic instability. Each cancer cell carries within itself genetic instability, and this instability increases the chances the cell will be able to mutate as needed to adapt to its environment.
2. Abnormal expression of genes. In essence, the function of genes is to make proteins - a process called gene expression. When they are expressed, some genes produce proteins that inhibit cancer progression, and others produce proteins that fascilitate it. In cancer cells, abnormal expression of genes occurs, resulting in too few proteins that inhibit cancer, and too many that fascilitate it.
3. Abnormal signal transduction. Signal transduction is the movement of a signal from outside the cell towards the cell's nucleus, where it can stimulate proliferation or other activities. One important source of external signals comes from growth factors. Growth factors are solvable molecules at bind to specific receptors on the cell's surface and stimulate the cell's activities. A second source of external signals comes from cell adhesion molecules (CAMs). Cell's interact with their environment through CAMs located on their surface. Cell adhesion molecules are proteins that act like fingers to regulate the degree of contact with other cell's and tissues and inform cell's of their surroundings. Other factors are also involved in signal generation and signal transduction. For example, cancer cells can produce their own growth factors, thereby allowing self-stimulation; they can produce extra receptors for growth factors; they can produce free radicals, which can make growth factor receptors more responsive to stimulation.
4. Abnormal cell-to-cell communication. By decreasing their contact with normal cells, cancer cells are freed to act independently. As mentioned previously, cell-to-cell communication occurs via portals between adjacent cells (gap junctions)and through cell adhesion molecules. Normal cell-to-cell communication through gap junctions maintains homeostasis and discourages cancerlike behavior. Normal CAM activity keeps cells in place and prevents signal transduction that may be initiated by abnormal CAM activity.
5. Induction of angiogenesis. Angiogenesis is the growth of new blood vessels toward and within tumors (or other tissues). Solid tumors require angiogenesis in order to grow. Tumors need blood vessels to supply oxygen and nutrients, and the blood vessels created by angiogenesis provide the channel by which tumor cells metastasize to distant locations.
6. Invasion and metastasis.. Tumors can spread both locally, via invasion of adjacent tissues, and distantly, via metastasis through the blood and lymph circulation. The spread of cancer, along with uncontrolled proliferation, is a central hallmark of malignancy.
7. Immune evasion Cancer cells shield themselves from immune attack, thereby evading destruction: they can hide from immune cells by employing various camouflaging techniques or can produce immunosuppressive compounds that impair the ability of immune cells to function.
These seven event clusters provide the targets for the anticancer strategies laid out in this book. Each of the seven clusters of procancer events is illustrated in Figure 1:1.
Since each of these seven clusters is a target for therapy, we can identify seven strategies for cancer inhibition. Keep in mind that natural compounds can be used to carry out each of these seven strategies and that the best results will be seen when all seven ar used together. The seven strategies are as follows:
1. Reduce genetic instability. Genetic instability is aggravated by oxidative stress (stress caused by free radicals). Cancer cells exist in an oxidative environment k and although such an environment kills, many continue to survive. As oxidative stress increases, the declining population of surviving cells exhibits greater instability and higher mutation rates, in theory eventually producing more aggressive and successful cancers. Thus one way of reducing genetic instability is by reducing oxidative stress. Other possible means of reducing genetic instability are discussed in Chapter 2.
2. Inhibit abnormal expression of genes. One way that gene expression can be normalized is through modifying the activity of transcription factors. Transcription factors are proteins that act as switches in the nucleus to turn on gene expression. Genes that inhibit cancer progression are commonly underexpressed in cancer cells, and genes that fascilitate cancer are often overexpressed. Therefore, cancer can be inhibited by normalizing the activity of those transcription factors that control the expression of these genes. The use of natural compounds to effect transcription factors is discussed in Chapter 5.
3. Inhibit abnormal signal transduction. The movement of a signal from outside the cell toward the nucleus relies on several proteins (including kinase enzymes and ras proteins, discussed later), and so signal transduction can be inhibited by blocking the the actions of these proteins; using natural compounds for this purpose is discussed in Chapter 4. Signal transduction is a normal process needed by healthy cells, but in cancer cells the volume of signal transduction is excessive, and the signals that flow favor proliferation and spread. Thus, the intent is not to eliminate signal transduction but to bring it down to normal levels.
4. Encourage normal cell-to-cell communication. Normal cell-to-cell communication can be fostered by by improving gap junction communication and by normalizing CAM activity. Natural compounds that encourage normal cell-to-cell communication are discussed in Chapter 6.
5. Inhibit tumor angiogenesis. Like signal transduction, angiogenesis is a normal process; it is needed during wound healing and in other situations. Angiogenesis in tumors, however, unlike that in normal conditions, is uncontrolled and ongoing. Our intent then is not to eliminate angiogenesis but to normalize its occurance by normalizing the factors that control it. Angiogenesis is most successful if certain chemicals called angiogenesis factors are present, as well as certain environmental conditions , such as hypoxia (low-oxygen) ones. Cancer can be inhibited by blocking the release or action of angiogenic factors or by otherwise altering the local environment to inhibit tumor angiogenesis. Natural compounds that that inhibit tumor angiogenesis are discussed in Chapters 7 and 8.
6. Inhibit invasion and metastasis. Invasion requires enzymatic digestion of the healthy tissue surrounding the tumor. It also requires the migration of tumor cells. Invasion can be reduces by inhibiting enzymes that digest local tissues, by protecting normal tissues from the enzymes, and by reducing the ability of tumor cells to migrate. Natural compounds that inhibit invasion are discussed in Chapter 9. Metastasis requires that cells detach from the primary tumor, enzymatically digest blood vessel walls to gain access to and exit from the blood circulation, and evade the immune system while in circulation. This metastasis can be checked by inhibiting any one of these processes. Natural compounds that do so are discussed in Chapter 10.
7. Increase the immune response. The immune response against cancer cells can be increased by stimulating the immune system and by reducing the ability of cancer cells to evade immune attack. Both actions are best taken in tandem, since without prevention of immune evasion, immune stimulation will have little benefit; healthy, vital immune cells can destroy cancer cells, but only if the cancer cells can be recognized as foreign to the body. Chapters 11 and 12 discuss the use of natural compounds to stimulate the immune system and inhibit immune evasion.
When natural compounds are used in these strategies, some will directly inhibit cancer cells , causing them to die, revert to normalcy (a process called differentiation), or just stop proliferating. Others will inhibit cancer progression indirectly by inducing changes in the local environment that are unfavorable to angiogenesis, invasion, or metastasis. This might include, for example, inhibiting the enzymes produced by cancer cells that allow invasion. Thus we can group natural compounds into two broad categories of action: those that act directly on cancer cells to inhibit proliferation (called direct-action compounds) and those that inhibit cancer progression by affecting tissues or compounds outside the cancer cell (called indirect-acting compounds). In addition we can add a third category: compounds that inhibit cancer through stimulating the immune system. Although immune attack produces a direct cytotoxic effect against cancer cells, immune stimulants themselves generally do not.
Bury your nose in enough study on a subject and you begin to translate the language. The rest of the book is a great read too, if you can get past the technical edge. I'm starting to find it all easy to read. 
